SYNCOM FORMULATIONS (INDIA)
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2017 | Mar2016 | Mar2015 | |
---|---|---|---|---|---|
Profit Before Tax | ₹27 Cr | ₹26 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Adjustment | ₹-6.11 Cr | ₹-7.16 Cr | ₹0.71 Cr | ₹1.14 Cr | ₹2.59 Cr |
Changes In working Capital | ₹-3.26 Cr | ₹3.58 Cr | ₹1.29 Cr | ₹12 Cr | ₹-12 Cr |
Cash Flow after changes in Working Capital | ₹17 Cr | ₹23 Cr | ₹18 Cr | ₹30 Cr | ₹6.69 Cr |
Cash Flow from Operating Activities | ₹11 Cr | ₹16 Cr | ₹14 Cr | ₹24 Cr | ₹0.19 Cr |
Cash Flow from Investing Activities | ₹-45 Cr | ₹-27 Cr | ₹-18 Cr | ₹-23 Cr | ₹0.63 Cr |
Cash Flow from Financing Activities | ₹35 Cr | ₹8.29 Cr | ₹4.67 Cr | ₹-2.41 Cr | ₹0.68 Cr |
Net Cash Inflow / Outflow | ₹0.58 Cr | ₹-2.45 Cr | ₹0.83 Cr | ₹-1.08 Cr | ₹1.50 Cr |
Opening Cash & Cash Equivalents | ₹0.30 Cr | ₹2.75 Cr | ₹5.69 Cr | ₹6.77 Cr | ₹5.28 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹0.88 Cr | ₹0.30 Cr | ₹6.52 Cr | ₹5.69 Cr | ₹6.77 Cr |
Compare Cashflow Statement of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,189.1 Cr | -3.1% | -23.6% | 96.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹368,766.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹111,102.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,958.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹99,939.6 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,104.2 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -3.1% |
-23.6% |
96.4% |
SENSEX | -2.4% |
-1% |
21.3% |
You may also like the below Video Courses